{
    "organizations": [],
    "uuid": "03e2b105d71cb61a5a6993c65de92dfca841add0",
    "author": "",
    "url": "https://www.reuters.com/article/brief-sun-pharmaceutical-industries-anno/brief-sun-pharmaceutical-industries-announces-settlement-of-patent-litigation-for-generic-linzess-in-u-s-idUSFWN1PB0UD",
    "ord_in_thread": 0,
    "title": "BRIEF-Sun Pharmaceutical Industries Announces Settlement Of Patent Litigation For Generic Linzess In U.S.",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 39 PM / Updated 12 minutes ago BRIEF-Sun Pharmaceutical Industries Announces Settlement Of Patent Litigation For Generic Linzess In U.S. Reuters Staff \nJan 16 (Reuters) - Sun Pharmaceutical Industries Ltd : \n* SAYS CO‘S UNITS HAVE REACHED AN AGREEMENT WITH IRONWOOD PHARMACEUTICALS, INC. AND ALLERGAN PLC \n* ANNOUNCES SETTLEMENT OF PATENT LITIGATION FOR GENERIC LINZES IN US \n* COMPANIES TO GRANT CO‘S UNITS LICENSE TO MARKET GENERIC VERSION OF LINZESS IN U.S FROM FEB 1, 2031 OR EARLIER UNDER CIRCUMSTANCES \n* ADDITIONAL DETAILS REGARDING THE SETTLEMENT WERE NOT DISCLOSED. Source text - bit.ly/2Dl8eOU  ",
    "published": "2018-01-16T15:38:00.000+02:00",
    "crawled": "2018-01-16T15:54:09.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "industry",
        "announces",
        "settlement",
        "patent",
        "litigation",
        "generic",
        "linzess",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "sun",
        "pharmaceutical",
        "industry",
        "ltd",
        "say",
        "co",
        "unit",
        "reached",
        "agreement",
        "ironwood",
        "pharmaceutical",
        "allergan",
        "plc",
        "announces",
        "settlement",
        "patent",
        "litigation",
        "generic",
        "linz",
        "u",
        "company",
        "grant",
        "co",
        "unit",
        "license",
        "market",
        "generic",
        "version",
        "linzess",
        "feb",
        "earlier",
        "circumstance",
        "additional",
        "detail",
        "regarding",
        "settlement",
        "disclosed",
        "source",
        "text"
    ]
}